The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: David A. Isenberg |
| Publication date | November 1, 1999 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |